VASP and non-small cell lung carcinoma: We then evaluated PDEi modulation of cAMP/PKA and cGMP/PKG signaling in NSCLC by measuring the phosphorylation of the downstream target vasodilator-stimulated protein (VASP, Figure 2C and Figure S2).